USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
29-Apr-2006
North America
Market Research
F205-01-00-00-00
HC01429-NA-MR_05888
Emerging Therapeutics in the U.S. Colorectal Cancer Market is a rapidly progressing field that is set to generate over $2 billion in revenue in the coming years. The market has witnessed unprecedented growth with the launch of a new segment and as a result competition has increased in the cytotoxic market. The dynamics of this market are changing rapidly and the forecast through 2011 highlights the major changes. This study includes patient forecasts, pipeline analysis and individual product revenue forecasts.
Emerging Therapeutics in the U.S. Colorectal Cancer Markets, U.S. Total Market for Colorectal Cancer
Executive Summary
- Executive Summary - Updated 4/2006
Research Scope and Methodology
- Scope and Segmentation
- Research Methodology
Disease Overview
- Introduction
- Etiology
- Screening
- Diagnosis and Staging
- Treatment Overview
Patient Forecasts
- Incidence and Staging Forecasts
- Patient Forecasts by Line of Therapy
- Unmet Need Population Forecasts
Total Market Forecasts
- Total Market Forecasts - Updated 4/2006
- Market Share Analysis - Updated 4/2006
- Adjuvant Therapy Forecasts - Updated 4/2006
- First-line Therapy Forecasts - Updated 4/2006
- Second and Third-line Therapy Forecasts - Updated 4/2006
General Market Trends
- Industry Challenges
- Market Drivers
- Market Restraints
Frost & Sullivan Awards
- Company of the Year Award
- Product of the Year Award
- Entrepreneurial Company of the Year Award
- Product Differentiation Innovation of the Year Award
- Best Bang for the Buck Award
Overview
Forecasts and Trends
Competitive Analysis
Overview
Angiogenesis Pathway
EGF Pathway
Cell Proliferation/Apoptosis Pathway
Immune Response Pathway
Revenue Forecasts
Competitive Analysis
Decision Support Databases
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
25 Sep 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Diagnostic Solutions, and Implantables
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, diagnostic solutions, and implantables.The issue features advanced medical devices such as peritoneal dialysis fluid system, cold sterilization-based au...
23 Sep 2026 | Global | Technology Research
Programmable Epigenome Editing for Disease Reversal
Programmable epigenome editing is developing as a distinct approach to controlling gene activity without changing the underlying DNA sequence. This report examines the landscape from the core editing technologies and delivery systems through the companies, academic programs and therapeutic applicati...
21 Sep 2026 | Europe | Market Research
HLTH Europe 2026: Five Key Takeaways and Growth Opportunities
HLTH Europe 2026, held in Amsterdam, brought together more than 5,000 stakeholders spanning providers, payers, health systems, technology vendors, start-ups, investors, and policymakers, providing a comprehensive view of the evolving European digital health landscape. Across conference sessions and ...
21 Sep 2026 | Global | Frost Radar
Frost Radar: Smart Nutraceuticals for Brain Health, 2026
This Frost Radar evaluates the evolving smart nutraceuticals landscape as consumer awareness of cognitive health, lifestyle-related stress, and healthy aging creates demand for scientifically validated, natural, and multifunctional brain health solutions. The market remains fragmented, with differen...
18 Sep 2026 | Global | Frost Radar
Frost Radar™: Life Sciences Laboratory Information Management Systems, 2026
Laboratory information management systems (LIMS) have been used in life sciences since laboratories began digitizing sample tracking and data management in the 1970s. Modern LIMS solutions enhance efficiency by automating workflows, improving data accuracy, and enabling seamless integration and offe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Industries | Healthcare |
| WIP Number | F205-01-00-00-00 |
| Is Prebook | No |
Emerging Therapeutics in the U.S. Colorectal Cancer Markets
$4,950.00
Special Price $3,712.50 save 25 %